Solentim Overview

  • Founded
  • 2010
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 51
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1
  • Investments
  • 1

Solentim General Information

Description

Designer and developer of biotechnology solutions designed for seeding, assurance and productivity measurements. The company's technology performs total plate laser focus scanning, adjusting for plate contours, to ensure an optimal focal position for each cell, enabling research labs to accelerate projects.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Other Devices and Supplies
Parent Company
Primary Office
  • Solent House, Johnson Road
  • Fernside Business Park, Stapehill
  • Wimborne BH21 7SE
  • England, United Kingdom
+44 01202 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Solentim Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Solentim‘s full profile, request access.

Request a free trial

Solentim Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Designer and developer of biotechnology solutions designed for seeding, assurance and productivity measurements. The com
Discovery Tools (Healthcare)
Wimborne, United Kingdom
51 As of 2021
0000 0000-00-00
000000000000

000000 0

lamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
000000000 00000 (0000000000)
Cambridge, United Kingdom
00 As of 0000
000.00
0000000000 0 000.00

00000000

ud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in re
0000000000000
Vancouver, Canada
0000 As of 0000
000.00
00000000. 00 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Solentim Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
00000000 000000000 Private Debt Financed Vancouver, Canada 0000 000.00 00000000. 00 000.00
00000 0000000000 Formerly PE-Backed Ann Arbor, MI 000 000000&0
000000 0000000000 Venture Capital-Backed Singapore, Singapore 00 00.00 00000000000 00.00
000000 0000000 Formerly PE-Backed Beverly, MA 00 000000
To view Solentim’s complete competitors history, request access »

Solentim Patents

Solentim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2551116-B Dispensing method and apparatus Active 31-May-2016 000000000
GB-2551116-A Dispensing method and apparatus Granted 31-May-2016 000000000
GB-201609508-D0 Dispensing method and apparatus Granted 31-May-2016 000000000
US-20210163875-A1 Cell imaging with growth matrices Pending 31-May-2016 000000000
US-20170342367-A1 Dispensing method and apparatus Pending 31-May-2016 C12M41/48 0
To view Solentim’s complete patent history, request access »

Solentim Executive Team (5)

Name Title Board Seat Contact Info
Mark Truesdale Ph.D Chief Executive Officer & Board Member
Catherine Petty Financial Controller
Ian Taylor Ph.D Chief Commercial Officer & Chief Business Officer
You’re viewing 3 of 5 executive team members. Get the full list »

Solentim Board Members (2)

Name Representing Role Since
000000 00000 Solentim Board Member 000 0000
0000 000000000 00.0 Solentim Chief Executive Officer & Board Member 000 0000
To view Solentim’s complete board members history, request access »

Solentim Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solentim Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 23-Feb-2021 00000 0000 Drug Discovery 0000 0000
To view Solentim’s complete investments history, request access »